
Sign up to save your podcasts
Or


Send a text
Welcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast! This week, Drs. Mike and John Fralick discuss two recent papers examining the effect of glucagon-like peptide-1 receptor agonists (GLP1's) on patients living with Parkinson’s disease. Two papers, here we go!
And for the Good Stuff:
This episode is sponsored by Northern Ontario Resident Streamlined Training and Reimbursement Program (NORSTAR). Check out details here!
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
By Dr. John Fralick and Dr. Michael Fralick5
1212 ratings
Send a text
Welcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast! This week, Drs. Mike and John Fralick discuss two recent papers examining the effect of glucagon-like peptide-1 receptor agonists (GLP1's) on patients living with Parkinson’s disease. Two papers, here we go!
And for the Good Stuff:
This episode is sponsored by Northern Ontario Resident Streamlined Training and Reimbursement Program (NORSTAR). Check out details here!
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

91,246 Listeners

43,818 Listeners

320 Listeners

542 Listeners

706 Listeners

501 Listeners

3,387 Listeners

1,141 Listeners

67 Listeners

520 Listeners

367 Listeners

258 Listeners

320 Listeners

10,983 Listeners

4,325 Listeners